APO Research
Talk to an analyst

APO RESEARCH · REPORT

Argininemia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Argininemia Drugs Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchArgininemia Drugs Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Argininemia Drugs Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Argininemia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Argininemia Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Argininemia Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Argininemia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Argininemia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Argininemia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Argininemia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Argininemia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Argininemia Drugs include Novartis Pharmaceuticals, Medicis Pharmaceutical, Horizo​​n Pharma and Helsinn Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Argininemia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Argininemia Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Argininemia Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Argininemia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Argininemia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Argininemia Drugs sales, projected growth trends, production technology, application and end-user industry.

Argininemia Drugs Segment by Company

Novartis Pharmaceuticals

Medicis Pharmaceutical

Horizo​​n Pharma

Helsinn Healthcare

Argininemia Drugs Segment by Type

Oral

Injection

Argininemia Drugs Segment by Application

Hospital

Drugs Stores

Other

Argininemia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Argininemia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Argininemia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Argininemia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Argininemia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Argininemia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Argininemia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Argininemia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Argininemia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drugs Stores Major Manufacturers Table 7. Other Major Manufacturers Table 8. Argininemia Drugs Industry Trends Table 9. Argininemia Drugs Industry Drivers Table 10. Argininemia Drugs Industry Opportunities and Challenges Table 11. Argininemia Drugs Industry Restraints Table 12. Global Argininemia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Argininemia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Argininemia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Argininemia Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Argininemia Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Argininemia Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Argininemia Drugs Sales by Region (2021-2026) & (k units) Table 19. Global Argininemia Drugs Sales by Region (2027-2032) & (k units) Table 20. Global Argininemia Drugs Sales Market Share by Region (2021-2026) Table 21. Global Argininemia Drugs Sales Market Share by Region (2027-2032) Table 22. Global Argininemia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Argininemia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Argininemia Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Argininemia Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Argininemia Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Argininemia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Argininemia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Argininemia Drugs Manufacturers, Product Type & Application Table 30. Global Argininemia Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Argininemia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Argininemia Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Argininemia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Argininemia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Argininemia Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Argininemia Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Argininemia Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Argininemia Drugs Sales by Type (2021-2026) & (k units) Table 40. Global Argininemia Drugs Sales by Type (2027-2032) & (k units) Table 41. Global Argininemia Drugs Sales Market Share by Type (2021-2026) Table 42. Global Argininemia Drugs Sales Market Share by Type (2027-2032) Table 43. Global Argininemia Drugs Price by Type (2021-2026) & (US$/unit) Table 44. Global Argininemia Drugs Price by Type (2027-2032) & (US$/unit) Table 45. Global Argininemia Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Argininemia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Argininemia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Argininemia Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Argininemia Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Argininemia Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Argininemia Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Argininemia Drugs Sales by Application (2027-2032) & (k units) Table 53. Global Argininemia Drugs Sales Market Share by Application (2021-2026) Table 54. Global Argininemia Drugs Sales Market Share by Application (2027-2032) Table 55. Global Argininemia Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Argininemia Drugs Price by Application (2027-2032) & (US$/unit) Table 57. Novartis Pharmaceuticals Company Information Table 58. Novartis Pharmaceuticals Business Overview Table 59. Novartis Pharmaceuticals Argininemia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Novartis Pharmaceuticals Argininemia Drugs Product Portfolio Table 61. Novartis Pharmaceuticals Recent Development Table 62. Medicis Pharmaceutical Company Information Table 63. Medicis Pharmaceutical Business Overview Table 64. Medicis Pharmaceutical Argininemia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Medicis Pharmaceutical Argininemia Drugs Product Portfolio Table 66. Medicis Pharmaceutical Recent Development Table 67. Horizo​​n Pharma Company Information Table 68. Horizo​​n Pharma Business Overview Table 69. Horizo​​n Pharma Argininemia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Horizo​​n Pharma Argininemia Drugs Product Portfolio Table 71. Horizo​​n Pharma Recent Development Table 72. Helsinn Healthcare Company Information Table 73. Helsinn Healthcare Business Overview Table 74. Helsinn Healthcare Argininemia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Helsinn Healthcare Argininemia Drugs Product Portfolio Table 76. Helsinn Healthcare Recent Development Table 77. North America Argininemia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Argininemia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Argininemia Drugs Sales by Type (2021-2026) & (k units) Table 80. North America Argininemia Drugs Sales by Type (2027-2032) & (k units) Table 81. North America Argininemia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 82. North America Argininemia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 83. North America Argininemia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Argininemia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Argininemia Drugs Sales by Application (2021-2026) & (k units) Table 86. North America Argininemia Drugs Sales by Application (2027-2032) & (k units) Table 87. North America Argininemia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 88. North America Argininemia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 89. North America Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Argininemia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Argininemia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 93. North America Argininemia Drugs Sales by Country (2021-2026) & (k units) Table 94. North America Argininemia Drugs Sales by Country (2027-2032) & (k units) Table 95. North America Argininemia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 96. North America Argininemia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 97. United States Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 98. Canada Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 99. Mexico Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 100. Europe Argininemia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Argininemia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Argininemia Drugs Sales by Type (2021-2026) & (k units) Table 103. Europe Argininemia Drugs Sales by Type (2027-2032) & (k units) Table 104. Europe Argininemia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 105. Europe Argininemia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 106. Europe Argininemia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Argininemia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Argininemia Drugs Sales by Application (2021-2026) & (k units) Table 109. Europe Argininemia Drugs Sales by Application (2027-2032) & (k units) Table 110. Europe Argininemia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 111. Europe Argininemia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 112. Europe Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Argininemia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Argininemia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 116. Europe Argininemia Drugs Sales by Country (2021-2026) & (k units) Table 117. Europe Argininemia Drugs Sales by Country (2027-2032) & (k units) Table 118. Europe Argininemia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 119. Europe Argininemia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 120. Germany Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 121. France Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 122. U.K. Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 123. Italy Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 124. Russia Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 125. Spain Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 127. Switzerland Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 128. Sweden Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 129. Poland Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 130. China Argininemia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. China Argininemia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. China Argininemia Drugs Sales by Type (2021-2026) & (k units) Table 133. China Argininemia Drugs Sales by Type (2027-2032) & (k units) Table 134. China Argininemia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 135. China Argininemia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 136. China Argininemia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. China Argininemia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. China Argininemia Drugs Sales by Application (2021-2026) & (k units) Table 139. China Argininemia Drugs Sales by Application (2027-2032) & (k units) Table 140. China Argininemia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 141. China Argininemia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 142. Asia Argininemia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Argininemia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Argininemia Drugs Sales by Type (2021-2026) & (k units) Table 145. Asia Argininemia Drugs Sales by Type (2027-2032) & (k units) Table 146. Asia Argininemia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 147. Asia Argininemia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 148. Asia Argininemia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Argininemia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Argininemia Drugs Sales by Application (2021-2026) & (k units) Table 151. Asia Argininemia Drugs Sales by Application (2027-2032) & (k units) Table 152. Asia Argininemia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 153. Asia Argininemia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 154. Asia Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Argininemia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Argininemia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 158. Asia Argininemia Drugs Sales by Country (2021-2026) & (k units) Table 159. Asia Argininemia Drugs Sales by Country (2027-2032) & (k units) Table 160. Asia Argininemia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 161. Asia Argininemia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 162. Japan Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 163. South Korea Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 164. India Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 165. Australia Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 166. Taiwan Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Argininemia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Argininemia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Argininemia Drugs Sales by Type (2021-2026) & (k units) Table 171. SAMEA Argininemia Drugs Sales by Type (2027-2032) & (k units) Table 172. SAMEA Argininemia Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 173. SAMEA Argininemia Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 174. SAMEA Argininemia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Argininemia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Argininemia Drugs Sales by Application (2021-2026) & (k units) Table 177. SAMEA Argininemia Drugs Sales by Application (2027-2032) & (k units) Table 178. SAMEA Argininemia Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 179. SAMEA Argininemia Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 180. SAMEA Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Argininemia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Argininemia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 184. SAMEA Argininemia Drugs Sales by Country (2021-2026) & (k units) Table 185. SAMEA Argininemia Drugs Sales by Country (2027-2032) & (k units) Table 186. SAMEA Argininemia Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 187. SAMEA Argininemia Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 188. Brazil Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 189. Argentina Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 190. Chile Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 191. Colombia Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 192. Peru Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 194. Israel Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 195. UAE Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 196. Turkey Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 197. Iran Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 198. Egypt Argininemia Drugs Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Argininemia Drugs Distributors List Table 202. Argininemia Drugs Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Argininemia Drugs Image Figure 2. Global Argininemia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Argininemia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Argininemia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Argininemia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drugs Stores Image Figure 10. Other Image Figure 11. Global Argininemia Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Argininemia Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Argininemia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Argininemia Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Argininemia Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Argininemia Drugs Sales (2021-2032) & (k units) Figure 17. Global Argininemia Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Argininemia Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Argininemia Drugs Sales YoY (2021-2032) & (k units) Figure 20. Europe Argininemia Drugs Sales YoY (2021-2032) & (k units) Figure 21. China Argininemia Drugs Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Argininemia Drugs Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Argininemia Drugs Sales YoY (2021-2032) & (k units) Figure 24. Global Argininemia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Argininemia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Argininemia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Argininemia Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Argininemia Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Argininemia Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Argininemia Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Argininemia Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Argininemia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Argininemia Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Argininemia Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Argininemia Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Argininemia Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Argininemia Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Argininemia Drugs Revenue Share by Type (2021-2032) Figure 40. North America Argininemia Drugs Sales Share by Type (2021-2032) Figure 41. North America Argininemia Drugs Revenue Share by Application (2021-2032) Figure 42. North America Argininemia Drugs Sales Share by Application (2021-2032) Figure 43. North America Argininemia Drugs Revenue Share by Country (2021-2032) Figure 44. North America Argininemia Drugs Sales Share by Country (2021-2032) Figure 45. Europe Argininemia Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Argininemia Drugs Sales Share by Type (2021-2032) Figure 47. Europe Argininemia Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Argininemia Drugs Sales Share by Application (2021-2032) Figure 49. Europe Argininemia Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Argininemia Drugs Sales Share by Country (2021-2032) Figure 51. China Argininemia Drugs Revenue Share by Type (2021-2032) Figure 52. China Argininemia Drugs Sales Share by Type (2021-2032) Figure 53. China Argininemia Drugs Revenue Share by Application (2021-2032) Figure 54. China Argininemia Drugs Sales Share by Application (2021-2032) Figure 55. Asia Argininemia Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Argininemia Drugs Sales Share by Type (2021-2032) Figure 57. Asia Argininemia Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Argininemia Drugs Sales Share by Application (2021-2032) Figure 59. Asia Argininemia Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Argininemia Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Argininemia Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Argininemia Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Argininemia Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Argininemia Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Argininemia Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Argininemia Drugs Sales Share by Country (2021-2032) Figure 67. Argininemia Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Argininemia Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Drugs Stores
  • Other
Companies covered
  • Novartis Pharmaceuticals
  • Medicis Pharmaceutical
  • Horizo​​n Pharma
  • Helsinn Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Argininemia Drugs Market by Type
  3. 1.2.1 Global Argininemia Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Argininemia Drugs Market by Application
  7. 1.3.1 Global Argininemia Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drugs Stores
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Argininemia Drugs Market Dynamics
  1. 2.1 Argininemia Drugs Industry Trends
  2. 2.2 Argininemia Drugs Industry Drivers
  3. 2.3 Argininemia Drugs Industry Opportunities and Challenges
  4. 2.4 Argininemia Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Argininemia Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Argininemia Drugs Revenue by Region
  3. 3.2.1 Global Argininemia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Argininemia Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Argininemia Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Argininemia Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Argininemia Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Argininemia Drugs Sales by Region
  9. 3.4.1 Global Argininemia Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Argininemia Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Argininemia Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Argininemia Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Argininemia Drugs Revenue by Manufacturers
  2. 4.1.1 Global Argininemia Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Argininemia Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Argininemia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Argininemia Drugs Sales by Manufacturers
  6. 4.2.1 Global Argininemia Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Argininemia Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Argininemia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Argininemia Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Argininemia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Argininemia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Argininemia Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Argininemia Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Argininemia Drugs Market CR5 and HHI
  16. 4.8.2 2025 Argininemia Drugs Tier 1, Tier 2, and Tier 3
5 Argininemia Drugs Market by Type
  1. 5.1 Global Argininemia Drugs Revenue by Type
  2. 5.1.1 Global Argininemia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Argininemia Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Argininemia Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Argininemia Drugs Sales by Type
  6. 5.2.1 Global Argininemia Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Argininemia Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Argininemia Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Argininemia Drugs Price by Type
6 Argininemia Drugs Market by Application
  1. 6.1 Global Argininemia Drugs Revenue by Application
  2. 6.1.1 Global Argininemia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Argininemia Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Argininemia Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Argininemia Drugs Sales by Application
  6. 6.2.1 Global Argininemia Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Argininemia Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Argininemia Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Argininemia Drugs Price by Application
7 Company Profiles
  1. 7.1 Novartis Pharmaceuticals
  2. 7.1.1 Novartis Pharmaceuticals Company Information
  3. 7.1.2 Novartis Pharmaceuticals Business Overview
  4. 7.1.3 Novartis Pharmaceuticals Argininemia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Pharmaceuticals Argininemia Drugs Product Portfolio
  6. 7.1.5 Novartis Pharmaceuticals Recent Developments
  7. 7.2 Medicis Pharmaceutical
  8. 7.2.1 Medicis Pharmaceutical Company Information
  9. 7.2.2 Medicis Pharmaceutical Business Overview
  10. 7.2.3 Medicis Pharmaceutical Argininemia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Medicis Pharmaceutical Argininemia Drugs Product Portfolio
  12. 7.2.5 Medicis Pharmaceutical Recent Developments
  13. 7.3 Horizo​​n Pharma
  14. 7.3.1 Horizo​​n Pharma Company Information
  15. 7.3.2 Horizo​​n Pharma Business Overview
  16. 7.3.3 Horizo​​n Pharma Argininemia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Horizo​​n Pharma Argininemia Drugs Product Portfolio
  18. 7.3.5 Horizo​​n Pharma Recent Developments
  19. 7.4 Helsinn Healthcare
  20. 7.4.1 Helsinn Healthcare Company Information
  21. 7.4.2 Helsinn Healthcare Business Overview
  22. 7.4.3 Helsinn Healthcare Argininemia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Helsinn Healthcare Argininemia Drugs Product Portfolio
  24. 7.4.5 Helsinn Healthcare Recent Developments
8 North America
  1. 8.1 North America Argininemia Drugs Market Size by Type
  2. 8.1.1 North America Argininemia Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Argininemia Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Argininemia Drugs Price by Type (2021-2032)
  5. 8.2 North America Argininemia Drugs Market Size by Application
  6. 8.2.1 North America Argininemia Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Argininemia Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Argininemia Drugs Price by Application (2021-2032)
  9. 8.3 North America Argininemia Drugs Market Size by Country
  10. 8.3.1 North America Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Argininemia Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Argininemia Drugs Market Size by Type
  2. 9.1.1 Europe Argininemia Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Argininemia Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Argininemia Drugs Price by Type (2021-2032)
  5. 9.2 Europe Argininemia Drugs Market Size by Application
  6. 9.2.1 Europe Argininemia Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Argininemia Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Argininemia Drugs Price by Application (2021-2032)
  9. 9.3 Europe Argininemia Drugs Market Size by Country
  10. 9.3.1 Europe Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Argininemia Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Argininemia Drugs Market Size by Type
  2. 10.1.1 China Argininemia Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Argininemia Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Argininemia Drugs Price by Type (2021-2032)
  5. 10.2 China Argininemia Drugs Market Size by Application
  6. 10.2.1 China Argininemia Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Argininemia Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Argininemia Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Argininemia Drugs Market Size by Type
  2. 11.1.1 Asia Argininemia Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Argininemia Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Argininemia Drugs Price by Type (2021-2032)
  5. 11.2 Asia Argininemia Drugs Market Size by Application
  6. 11.2.1 Asia Argininemia Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Argininemia Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Argininemia Drugs Price by Application (2021-2032)
  9. 11.3 Asia Argininemia Drugs Market Size by Country
  10. 11.3.1 Asia Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Argininemia Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Argininemia Drugs Market Size by Type
  2. 12.1.1 SAMEA Argininemia Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Argininemia Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Argininemia Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Argininemia Drugs Market Size by Application
  6. 12.2.1 SAMEA Argininemia Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Argininemia Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Argininemia Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Argininemia Drugs Market Size by Country
  10. 12.3.1 SAMEA Argininemia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Argininemia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Argininemia Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Argininemia Drugs Value Chain Analysis
  2. 13.1.1 Argininemia Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Argininemia Drugs Production Mode & Process
  6. 13.2 Argininemia Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Argininemia Drugs Distributors
  9. 13.2.3 Argininemia Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst